Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Pharmacology and Experimental Therapeutics|August 5, 2005
Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubulesNaohiko Anzai, Promsuk Jutabha, Atsushi Enomoto, et al.
Cancer Science|January 8, 2024
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activityJunryo Rii, Shinichi Sakamoto, Atsushi Mizokami, et al.
Cancer Letters|July 1, 2018
Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technologyYuchen Sun, Josefina Piñón Hofbauer, Manami Harada, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Interactions of human organic anion transporters with diureticsHabib Hasannejad, Michio Takeda, Kentarou Taki, et al.
Cancer Science|May 29, 2021
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptorJunryo Rii, Shinichi Sakamoto, Masahiro Sugiura, et al.
Scientific Reports|June 2, 2021
The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2Maihulan Maimaiti, Shinichi Sakamoto, Masahiro Sugiura, et al.
Scientific Reports|January 30, 2020
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinomaMaihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, et al.
Circulation Reports|March 11, 2021
Evidence for Urate Uptake Through Monocarboxylate Transporter 9 Expressed in Mammalian Cells and Its Enhancement by Heat ShockNaoyuki Otani, Yasutaka Kurata, Nani Maharani, et al.
Translational Oncology|October 23, 2020
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancerMasahiro Sugiura, Hiroaki Sato, Atsushi Okabe, et al.
Cancer Science|April 24, 2024
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanismShinpei Saito, Keisuke Ando, Shinichi Sakamoto, et al.
Pageof 19